Solitomab, CAS 1005198-65-1

Product Description: Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Ferrari F, et al. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. J Exp Clin Cancer Res. 2015 Oct 17;34:123./[2]English DP, et al. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo. Cancer. 2015 Feb 1;121(3):403-12.

CAS Number: 1005198-65-1

Molecular Weight: N/A

Compound Purity: 98.15

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD3

• Artikelnummer: MEXHY-P99592-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99592-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated